SP600125

Catalog No. A10860

SP600125是一种JNK抑制剂,对于JNK-1和JNK-2,IC50 = 40 nM,对于JNK-3,IC50 = 90 nM。
  • Tetsuya Kouno, .et al. Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway, J Biol Chem, 2022, Jul;298(7):102056 PMID: 35605662
  • Mark P Roberto, .et al. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis, Immunity, 2021, Aug 10;54(8):1807-1824.e14 PMID: 34380064
  • Yang PM, .et al. p38α/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinoma, Am J Cancer Res, 2019, Oct 1;9(10):2120-2139 PMID: 31720078
  • Byungki Jang, .et al. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells, Int J Mol Sci, 2017, Nov; 18(11): 2258 PMID: 29077055
  • Yuki Haga, .et al. Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines, PLoS One, 2017, 12(3): e0174153 PMID: 28323861
  • Jia-Shiuan Tsai, .et al. Cadmium Activates Multiple Signaling Pathways That Coordinately Stimulate Akt Activity to Enhance c-Myc mRNA Stability, PLoS One, 2016, 11(1): e0147011 PMID: 26751215
  • Choe YJ, .et al. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53., Int J Oncol., 2014, 44(3):761-8. PMID: 24366007
Catalog Num A10860
M. Wt 220.2
Formula C14H8N2O
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 129-56-6
Synonyms
SMILES C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
SP600125是一种JNK抑制剂,对于JNK-1和JNK-2,IC50 = 40 nM,对于JNK-3,IC50 = 90 nM。
Targets
Target Value
JNK1IC50: 40nM
JNK2IC50: 40nM
AuroraAIC50: 60nM
TrkAIC50: 70nM
JNK3IC50: 90nM
FLT3IC50: 90nM
MKK4IC50: 0.4μM
MKK6IC50: 1.0μM
PKBIC50: 1.0μM
MKK3IC50: 1.5μM
PKCαIC50: 1.5μM
p56LCKIC50: 4.3μM
MKK7IC50: 5.1μM
MEKK1IC50: >10μM
ERK2IC50: >10μM
p38βIC50: >10μM
PKAIC50: >10μM
PKCIC50: >10μM
PKCθIC50: >10μM
Chk1IC50: >10μM
EGFIC50: >10μM
IKK1IC50: >10μM
IKK2IC50: >10μM
In vitro (25°C) DMSO 43 mg/mL (195.25 mM)
Water Insoluble
Ethanol Insoluble
In vivo 5%DMSO+40%PEG300+5%Tween80+50%ddH2O 1 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 45.41 mL 227.07 mL 454.13 mL
0.5 mM 9.08 mL 45.41 mL 90.83 mL
1 mM 4.54 mL 22.71 mL 45.41 mL
5 mM 0.91 mL 4.54 mL 9.08 mL

*The above data is based on the productmolecular weight 220.2 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.